Many on Wall Street said the company overpaid in its purchase of Frutarom and its merger with DuPont’s Nutrition & Biosciences division in 2018 and 2019. The $7.1 billion Frutarom deal, in particular, ...
Its portfolio has changed in recent years with the acquisition of DuPont's nutrition and biosciences business in 2021 and Frutarom in 2018. IFF holds an enviable portfolio focused on value-added ...